Narryer soars on rare earth hits
Narryer Metals lifted on rare earth hits in WA’s Great Southern, where former Cassini Resources boss Richard Bevan is chasing his next win.
Stockhead
ASX dips; fingers crossed for Nvidia earnings
The ASX dipped on Wednesday as energy stocks led losses. Global tensions weighed on markets but gold stocks rose… all ahead of Nvidia’s incoming earnings report.
Geopolitics shake traders; Narryer up 80pc
The ASX dips amid geopolitical tensions, Amcor falls on $13 billion acquisition, while Narryer Metals strikes high-grade scandium and rare earths.
Painchek seeks FDA nod for pain detection device
Painchek is eyeing a US market of 1.7 million aged-care beds for its mobile-based pain detection tool.
ASX biotechs await the ‘Trumpcare’ fallout
Donald Trump’s appointment of Robert F Kennedy Junior as health czar means interesting times for US-focused ASX life sciences plays
ASX IPOs are alive again
The ASX IPO market is picking up after a quiet 2024 with major listings ahead, including Symal, Fulcrum and Cuscal.
Petratherm shines on testing success
Metallurgical testing has proved that titanium minerals are present at the Rosewood prospect – a huge boost for Petratherm.
ASX on a high as tech stocks lead
The ASX kissed a record high on Tuesday, led by tech, energy and gold stocks, with gold rising above US$2600.
ASX tech, gold and energy stocks rise
The ASX has risen on Tuesday, with energy stocks up and Petratherm hitting high-grade titanium in South Australia.
Sonic affirms earnings and more acquisitions
Pathology and radiology giant Sonic Healthcare is recovering from its post-pandemic malaise and says earnings should improve this year.
Everyone wants a slice of this WA gold field
Record gold prices and corporate activity have shined a light on WA’s Laverton gold field, where these explorers are chasing new discoveries.
Can Echo IQ keep things pumping?
With FDA approval in the bag for its AI-based aortic stenosis diagnostic tool, Echo IQ is focused on commercialisation over the next few years.
ASX up, uranium stocks rise
The ASX closing bell has rung, with the local bourse ending Monday on a positive note. Mining gains offset tech and bank losses, while uranium stocks soared.
Tungsten merger has tongues wagging
A $13.5m tungsten deal, a cheap silver explorer and a uranium enrichment play are among the Aussie resources stocks posting gains on Monday.
ASX flat but Alderan up on copper hit
The ASX is trading flat as US rate fears weigh. Meanwhile NAB has been hit by a lawsuit and new bank levy, and Alderan jumps on copper-drilling hit in the US.
Heart valve tool gets a pump
Harvard University’s main teaching hospital will use Echo IQ’s AI-based Echosolv tool to detect aortic stenosis (heart valve disease). Tim Boreham reports.
Geothermal, nuclear powering data centres
Geothermal and nuclear energy have emerged as the top choice to power Big Tech’s data centres. These ASX companies are on the case.
The ASX’s cheapest silver explorer
With a market cap of just $6m, Silver hunter Sierra Nevada Gold may be the next cab off the rank in the ASX silver revival.
How short squeezes create buys
Pilbara Minerals tops the ASX short-selling list again, but buying heavily shorted stocks could trigger a short squeeze.
Listed brokers are in the thick of takeover action
Emerging competing takeover offers for SelfWealth and E&P Financial’s pending privatisation reflect the poor track record of the listed brokers.
Original URL: https://www.news.com.au/finance/business/stockhead